Indiva Ltd
Indiva Limited engages in the production, processing, and sale of cannabis and cannabis related products in Canada. It offers edibles, capsules and tablets, and vape products under the No Future, Pearls by gron, Bhang Chocolate, Indiva Doppio, Indiva Blips, and Indiva 1432 brands. Indiva Limited is based in Ottawa, Canada. As of November 4, 2024, Indiva Limited operates as a subsidiary of SNDL In… Read more
Indiva Ltd (NDVAF) - Net Assets
Latest net assets as of March 2024: $-1.28 Million USD
Based on the latest financial reports, Indiva Ltd (NDVAF) has net assets worth $-1.28 Million USD as of March 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($37.81 Million) and total liabilities ($39.10 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-1.28 Million |
| % of Total Assets | -3.39% |
| Annual Growth Rate | N/A |
| 5-Year Change | -101.78% |
| 10-Year Change | -415.47% |
| Growth Volatility | 12065.22 |
Indiva Ltd - Net Assets Trend (2001–2023)
This chart illustrates how Indiva Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Indiva Ltd (2001–2023)
The table below shows the annual net assets of Indiva Ltd from 2001 to 2023.
| Year | Net Assets | Change |
|---|---|---|
| 2023-12-31 | $-342.87K | -115.96% |
| 2022-12-31 | $2.15 Million | -82.58% |
| 2021-12-31 | $12.33 Million | +9.90% |
| 2020-12-31 | $11.22 Million | -41.84% |
| 2019-12-31 | $19.29 Million | -34.37% |
| 2018-12-31 | $29.40 Million | +56.19% |
| 2017-12-31 | $18.82 Million | +48437.90% |
| 2017-10-31 | $38.77K | -98.43% |
| 2016-12-31 | $2.47 Million | +2170.75% |
| 2016-10-31 | $108.69K | +148.30% |
| 2015-12-31 | $43.77K | -93.58% |
| 2014-12-31 | $681.70K | +968.87% |
| 2013-12-31 | $-78.46K | -762.19% |
| 2012-12-31 | $-9.10K | +95.70% |
| 2011-12-31 | $-211.68K | -117.13% |
| 2010-12-31 | $-97.49K | -119.50% |
| 2009-12-31 | $500.07K | -57.88% |
| 2008-12-31 | $1.19 Million | -58.97% |
| 2007-12-31 | $2.89 Million | +2.88% |
| 2006-12-31 | $2.81 Million | +1431.82% |
| 2005-12-31 | $-211.18K | +66.33% |
| 2004-12-31 | $-627.19K | -62.97% |
| 2003-12-31 | $-384.86K | -79.34% |
| 2002-12-31 | $-214.60K | -81.63% |
| 2001-12-31 | $-118.15K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Indiva Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 6857642900.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2023)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $59.92 Million | % |
| Other Comprehensive Income | $4.98 Million | % |
| Other Components | $7.15 Million | % |
| Total Equity | $-342.87K | 100.00% |
Indiva Ltd Competitors by Market Cap
The table below lists competitors of Indiva Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
HLT Global Bhd
KLSE:0188
|
$3.07 Million |
|
EA Holdings Bhd
KLSE:0154
|
$3.07 Million |
|
BluGlass Limited
PINK:BUGLF
|
$3.07 Million |
|
Amplitech Group, Inc. Series B Right
NASDAQ:AMPGZ
|
$3.07 Million |
|
Bedding World Co., Ltd.
TWO:2938
|
$3.06 Million |
|
WestBond Enterprises Corporation
PINK:WBNEF
|
$3.06 Million |
|
Sixty North Gold Mining Ltd
PINK:SXNTF
|
$3.06 Million |
|
Winnergy Medical Public Company Limited
BK:WINMED
|
$3.06 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Indiva Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2022 to 2023, total equity changed from 2,148,535 to -342,870, a change of -2,491,405 (-116.0%).
- Net loss of 4,918,000 reduced equity.
- New share issuances of 472,473 increased equity.
- Other comprehensive income decreased equity by 1,243,037.
- Other factors increased equity by 3,197,159.
Equity Change Factors (2022 to 2023)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-4.92 Million | -1434.36% |
| Share Issuances | $472.47K | +137.8% |
| Other Comprehensive Income | $-1.24 Million | -362.54% |
| Other Changes | $3.20 Million | +932.47% |
| Total Change | $- | -115.96% |
Book Value vs Market Value Analysis
This analysis compares Indiva Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2001-12-31 | $-18.17 | $0.02 | x |
| 2002-12-31 | $-32.99 | $0.02 | x |
| 2003-12-31 | $-59.17 | $0.02 | x |
| 2004-12-31 | $-96.43 | $0.02 | x |
| 2005-12-31 | $-22.85 | $0.02 | x |
| 2006-12-31 | $255.92 | $0.02 | x |
| 2007-12-31 | $158.00 | $0.02 | x |
| 2008-12-31 | $60.64 | $0.02 | x |
| 2009-12-31 | $22.54 | $0.02 | x |
| 2010-12-31 | $-2.58 | $0.02 | x |
| 2011-12-31 | $-3.05 | $0.02 | x |
| 2012-12-31 | $-0.12 | $0.02 | x |
| 2013-12-31 | $-0.81 | $0.02 | x |
| 2014-12-31 | $2.95 | $0.02 | x |
| 2015-12-31 | $0.16 | $0.02 | x |
| 2016-10-31 | $0.00 | $0.02 | x |
| 2016-12-31 | $0.12 | $0.02 | x |
| 2017-10-31 | $0.00 | $0.02 | x |
| 2017-12-31 | $0.49 | $0.02 | x |
| 2018-12-31 | $0.37 | $0.02 | x |
| 2019-12-31 | $0.23 | $0.02 | x |
| 2020-12-31 | $0.12 | $0.02 | x |
| 2021-12-31 | $0.09 | $0.02 | x |
| 2022-12-31 | $0.02 | $0.02 | x |
| 2023-12-31 | $0.00 | $0.02 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Indiva Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -13.09%
- • Asset Turnover: 0.99x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-181.88%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2001 | 0.00% | -258.53% | 0.20x | 0.00x | $-157.75K |
| 2002 | 0.00% | -79.33% | 0.88x | 0.00x | $-74.99K |
| 2003 | 0.00% | -243.37% | 0.43x | 0.00x | $-131.78K |
| 2004 | 0.00% | -1035.33% | 0.30x | 0.00x | $-333.98K |
| 2005 | 0.00% | -1106.39% | 0.14x | 0.00x | $-171.47K |
| 2006 | -13.42% | -1295.41% | 0.01x | 1.25x | $-658.59K |
| 2007 | -14.48% | -1794.57% | 0.01x | 1.31x | $-708.38K |
| 2008 | -256.50% | 0.00% | 0.00x | 1.67x | $-3.16 Million |
| 2009 | -137.38% | 0.00% | 0.00x | 2.55x | $-737.01K |
| 2010 | 0.00% | 0.00% | 0.00x | 0.00x | $-1.42 Million |
| 2011 | 0.00% | 0.00% | 0.00x | 0.00x | $-88.83K |
| 2012 | 0.00% | 0.00% | 0.00x | 0.00x | $-81.78K |
| 2013 | 0.00% | 0.00% | 0.00x | 0.00x | $-75.51K |
| 2014 | -168.40% | 0.00% | 0.00x | 1.23x | $-1.22 Million |
| 2015 | -1754.55% | 0.00% | 0.00x | 4.02x | $-772.38K |
| 2016 | -290.71% | 0.00% | 0.00x | 2.37x | $-326.83K |
| 2016 | -47.53% | 0.00% | 0.00x | 1.74x | $-1.42 Million |
| 2017 | -990.38% | 0.00% | 0.00x | 184.14x | $-387.89K |
| 2017 | -15.84% | 0.00% | 0.00x | 1.46x | $-4.86 Million |
| 2018 | -29.01% | -14624.32% | 0.00x | 1.22x | $-11.47 Million |
| 2019 | -59.08% | -1233.73% | 0.02x | 1.98x | $-13.33 Million |
| 2020 | -137.46% | -105.27% | 0.37x | 3.49x | $-16.54 Million |
| 2021 | -123.41% | -46.86% | 0.77x | 3.44x | $-16.45 Million |
| 2022 | -508.81% | -31.78% | 0.91x | 17.62x | $-11.15 Million |
| 2023 | 0.00% | -13.09% | 0.99x | 0.00x | $-4.88 Million |
Industry Comparison
This section compares Indiva Ltd's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $548,450,613
- Average return on equity (ROE) among peers: -450.37%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Indiva Ltd (NDVAF) | $-1.28 Million | 0.00% | N/A | $3.06 Million |
| Ascend Wellness Holdings Inc (AAWH) | $142.87 Million | -33.75% | 5.44x | $48.90 Million |
| AB Science S.A (ABSCF) | $10.73 Million | -252.65% | 3.71x | $39.89 Million |
| Alterola Biotech Inc (ABTI) | $4.85K | -2005.32% | 0.49x | $603.58K |
| Aurora Cannabis Inc (ACB) | $2.04 Billion | -34.08% | 0.34x | $199.15 Million |
| Acreage Holdings Inc (ACRDF) | $204.27 Million | -30.85% | 1.41x | $13.48K |
| Acura Pharmaceuticals Inc (ACUR) | $7.90 Million | -63.15% | 1.15x | $13.20K |
| Agra Ventures Ltd. (AGFAF) | $1.51 Million | -44.22% | 0.06x | $298.23K |
| Allergy Therapeutics plc (AGYTF) | $2.07 Million | -2084.75% | 31.32x | $25.30 Million |
| Aida Pharmaceuticals Inc (AIDA) | $6.67 Million | 24.51% | 2.78x | $1.80 |
| Adcock Ingram Holdings Limited (AIHLF) | $3.07 Billion | 20.55% | 0.55x | $85.61 Million |